These effects, along with a previous report demonstrating that a small-molecule ACKR3 agonist CCX771 displays anxiolytic-like conduct in mice,two guidance the strategy of targeting ACKR3 as a novel way to modulate the opioid process, which could open new therapeutic avenues for opioid-linked disorders. A investigate review printed in Anesthesiology https://heinzp724iop1.is-blog.com/profile